Drug Research Transformation is Possible in 2022

We often imagine futuristic AI computers, 3D-printed organs, and robot surgeons when we think of new medical advances. However, the more ambitious and less-explored approaches to drug discovery and development that are currently being used could prove to be just as interesting. According to a recent GlobalData survey, over 70% of pharma sector respondents believe that smart technology deployment will have the greatest influence on drug development.

Pharmaceutical Technology looks at some of the technical advancements and approaches that could alter drug Research in 2022 as the year draws to a close. In terms of speed and performance, supercomputers are far superior to general-purpose computers, and they are especially useful for scientific and data-intensive jobs. It’s no surprise that Research are attempting to use supercomputing to speed up the time-consuming process of medication discovery and development.

This year, NVIDIA, a California-based technology corporation, unveiled Cambridge-1, the UK’s most powerful supercomputer, to aid British healthcare Research in addressing some of the industry’s most pressing issues. NVIDIA also announced a series of collaborations with pharma behemoths AstraZeneca and GlaxoSmithKline, as well as institutions including Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, and Oxford Nanopore Technologies, in conjunction with the debut of Cambridge-1.

Every stage of drug discovery might be considerably accelerated and optimised using the Cambridge-1 supercomputer. NVIDIA is working with AstraZeneca to develop a transformer-based generative AI model for chemical structures, which will allow Research to use self-supervised training approaches to exploit enormous datasets and speed up drug discovery.